Question 1

What is the share price of Senores Pharmaceuticals Ltd today?

Accepted Answer

Senores Pharmaceuticals Ltd (SENORES) is trading at ₹1,215.3. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is SENORES’s P/E ratio versus the sector?

Accepted Answer

SENORES trades at a P/E of 348.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is SENORES’s dividend yield?

Accepted Answer

SENORES has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is SENORES’s 52-week high and low?

Accepted Answer

SENORES has traded between ₹706 and ₹1,599 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Senores Pharmaceuticals Ltd?

Accepted Answer

Senores Pharmaceuticals Ltd has a market capitalisation of ₹6,465 crore.

Question 6

What is SENORES’s return on equity?

Accepted Answer

SENORES reports a return on equity of 2.8%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - General.

Question 7

Who are SENORES’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - General companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is SENORES’s promoter holding?

Accepted Answer

Promoters hold 45.82% of SENORES. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include SENORES?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight SENORES carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Senores Pharmaceuticals Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from SENORES’s own numbers. The judgement is yours.

Revenue	₹106 crore
Net profit	₹20 crore
Operating margin	-18%
EPS	₹4.4

SENORES

SENORES

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

SENORES financial summary